Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation; [Eisenmangel oder Entzündungsanämie?: Differenzialdiagnose und Mechanismen der Entzündungsanämie]

被引：92
作者：
Nairz M. [1 ]
Theurl I. [1 ]
Wolf D. [2 ]
Weiss G. [1 ]
机构：
[1] Department of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Anichstraße 35, Innsbruck
[2] Medical Clinic III, Department of Oncology, Hematology and Rheumatology, University Clinic Bonn (UKB), Bonn
来源：
Wiener Medizinische Wochenschrift | 2016年 / 166卷 / 13-14期
关键词：
Anemia of chronic disease; Anemia of inflammation; Hepcidin; Iron; Macrophage;
D O I：
10.1007/s10354-016-0505-7
中图分类号：
学科分类号：
摘要：
Iron deficiency and immune activation are the two most frequent causes of anemia, both of which are based on disturbances of iron homeostasis. Iron deficiency anemia results from a reduction of the body’s iron content due to blood loss, inadequate dietary iron intake, its malabsorption, or increased iron demand. Immune activation drives a diversion of iron fluxes from the erythropoietic bone marrow, where hemoglobinization takes place, to storage sites, particularly the mononuclear phagocytes system in liver and spleen. This results in iron-limited erythropoiesis and anemia. This review summarizes current diagnostic and pathophysiological concepts of iron deficiency anemia and anemia of inflammation, as well as combined conditions, and provides a brief outlook on novel therapeutic options. © 2016, The Author(s).
引用
收藏
页码：411 / 423
页数：12
相关论文
共 160 条
[11]  
Kassebaum N.J., Jasrasaria R., Naghavi M., Et al., A systematic analysis of global anemia burden from 1990 to 2010, Blood, 123, pp. 615-624, (2014)
[12]  
Weiss G., Anemia of chronic disorders: new diagnostic tools and new treatment strategies, Semin. Hematol., 52, pp. 313-320, (2015)
[13]  
Goodnough L.T., Nemeth E., Ganz T., Detection, evaluation, and management of iron-restricted erythropoiesis, Blood, 116, pp. 4754-4761, (2010)
[14]  
Thomas L., Franck S., Messinger M., Linssen J., Thome M., Thomas C., Reticulocyte hemoglobin measurement – comparison of two methods in the diagnosis of iron-restricted erythropoiesis, Clin. Chem. Lab. Med., 43, pp. 1193-1202, (2005)
[15]  
Archer N.M., Brugnara C., Diagnosis of iron-deficient states, Crit Rev Clin Lab Sci, 52, pp. 256-272, (2015)
[16]  
Jankowska E.A., Rozentryt P., Witkowska A., Et al., Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure, J. Card. Fail., 17, pp. 899-906, (2011)
[17]  
Oexle H., Gnaiger E., Weiss G., Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation, Biochim. Biophys. Acta, 1413, pp. 99-107, (1999)
[18]  
Rensvold J.W., Ong S.E., Jeevananthan A., Carr S.A., Mootha V.K., Pagliarini D.J., Complementary RNA and protein profiling identifies iron as a key regulator of mitochondrial biogenesis, Cell Rep, 3, pp. 237-245, (2013)
[19]  
Ezekowitz J.A., McAlister F.A., Armstrong P.W., Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure, Circulation, 107, pp. 223-225, (2003)
[20]  
Mozaffarian D., Nye R., Levy W.C., Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE), J. Am. Coll. Cardiol., 41, pp. 1933-1939, (2003)
12345678910